RIFGUARD 550 TAB'S 15'S

About

RIFGUARD 550 TAB'S contains Rifaximin, a non-systemic antibiotic that acts locally within the gastrointestinal tract. Unlike many other antibiotics, Rifaximin has minimal systemic absorption, meaning very little of the drug enters the bloodstream. This localized action allows it to effectively target and reduce the bacterial load in the gut without significantly affecting the body's overall microbial balance or contributing to systemic antibiotic resistance. It works by inhibiting bacterial RNA synthesis, thereby preventing bacterial growth and replication.

This unique pharmacokinetic profile makes Rifaximin particularly useful for treating conditions where bacterial overgrowth or altered gut flora contribute to symptoms. It is highly effective against a broad spectrum of gut bacteria, including both gram-positive and gram-negative anaerobes and aerobes. Its primary applications include managing conditions like hepatic encephalopathy by reducing ammonia-producing bacteria, and treating irritable bowel syndrome with diarrhea (IBS-D) by modulating gut microbiota and reducing inflammation.

Uses

• Hepatic encephalopathy (reduction of recurrence)
• Irritable bowel syndrome with diarrhea (IBS-D)
• Traveler's diarrhea caused by non-invasive strains of E. coli
• Small intestinal bacterial overgrowth (SIBO)

Directions For Use

Take orally as directed by your doctor, usually with or without food.

Benefits

• Localized action within the gut, minimal systemic absorption
• Reduces ammonia-producing bacteria in hepatic encephalopathy
• Improves symptoms of irritable bowel syndrome with diarrhea
• Effective for treating traveler's diarrhea
• Low risk of systemic side effects
• Helps modulate gut microbiota balance

Side Effects

• Peripheral edema
• Dizziness
• Nausea
• Abdominal pain
• Fatigue
• Headache
• Flatulence
• Constipation
• Diarrhea
• Muscle spasms
• Pruritus
• Rash

Safety Measures

• Alcohol - Avoid or limit alcohol consumption, as it can exacerbate underlying liver conditions, especially in patients with hepatic encephalopathy.
• Pregnancy - Use only if clearly needed and the potential benefit outweighs the risk; consult a healthcare professional.
• Breastfeeding - Caution advised as it is unknown if Rifaximin is excreted in human milk. Consult your doctor.
• Liver - Used to treat hepatic encephalopathy; generally safe for liver conditions, but monitor patients with severe hepatic impairment.
• Kidney - No dose adjustment is typically needed for patients with renal impairment due to minimal systemic absorption.
• Lung - No specific lung-related precautions; generally safe for patients with lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.